Jennifer L Good Net Worth - Insider Trades and Bio as of Jun 28, 2026

TRVITrevi Therapeutics, Inc.SEC CIK: 0001229245

Estimated Net Worth

$6.96 Million

Last Updated: May 19, 2026 11:11 PM EST

Transaction Summary

Total Transactions58

Buy-Sell Ratio0.15

Buy Transactions2

Sell Transactions13

Transaction Volume

Total Volume-$3.87M

Net Volume$3.91M

Buy Volume$16.05K

Sell Volume-$3.89M

Trade Analysis

AVG Trade Size-$9.16K

Largest Trade$1.13M

Most Active MonthJun

Most Active Year2024

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Jennifer L Good has an estimated net worth of $6.96 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., XTL BIOPHARMACEUTICALS LTD, Trevi Therapeutics, Inc., JUNIPER PHARMACEUTICALS INC, and PENWEST PHARMACEUTICALS CO.

2024 was Jennifer L Good's most active year for acquiring shares with 22 total transactions. Jennifer L Good's most active month to acquire stocks was the month of August. 2024 was Jennifer L Good's most active year for disposing of shares, totalling 29 transactions. Jennifer L Good's most active month to dispose stocks was the month of August. 2006 saw Jennifer L Good paying a total of $1,133,500.00 for 50,000 shares, this is the most they've acquired in one year. In 2024 Jennifer L Good cashed out on 351,590 shares for a total of $4,541,445.58, their largest year based on trade value.

Holdings & Transactions

TRVItrevi therapeutics, inc.

President & CEO

Updated: Feb 20, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	675.00K	—	—	Feb 20, 2026	675.00K	Grant	—	Feb 19	View
From 4	1.88	102.00K	—	—	Jun 03, 2025	156.40K	Grant	—	May 31	View
From 4	-0.02	5.26K	$4.01	-$27.10K	Mar 25, 2025	213.31K	Sale	—	Mar 21	View
From 4	—	54.40K	—	—	Mar 12, 2025	54.40K	Grant	—	Mar 10	View
From 4	—	811.00K	—	—	Feb 20, 2025	811.00K	Grant	—	Feb 18	View
From 4	-0.03	6.06K	$2.23	-$9.71K	Sep 09, 2024	213.31K	Sale	—	Sep 06 - 09	View
From 4	-0.20	55.12K	$2.26	-$91.37K	Sep 05, 2024	219.37K	Sale	—	Sep 03 - 05	View
From 4	-0.09	25.04K	$2.53	-$16.74K	May 22, 2024	246.50K	Sale	—	May 20	View
From 4	-0.02	4.58K	$2.55	-$3.25K	May 14, 2024	271.54K	Sale	—	May 10	View
From 4	—	630.00K	—	—	Feb 16, 2024	630.00K	Grant	—	Feb 15	View
From 4	—	375.00K	—	—	Feb 16, 2023	375.00K	Grant	—	Feb 16	View
From 4	0.25	32.00K	—	—	Sep 19, 2022	160.00K	Grant	—	Sep 19	View
From 4	—	128.00K	—	—	Jul 01, 2022	128.00K	Grant	—	Jun 29	View
From 4/A	—	275.00K	—	—	Jul 01, 2022	275.00K	Grant	—	Feb 14	View
From 4	—	275.00K	—	—	Feb 15, 2022	275.00K	Grant	—	Feb 14	View
From 4	—	160.00K	—	—	Feb 19, 2021	160.00K	Grant	—	Feb 17	View
From 4	—	200.00K	—	—	Feb 18, 2020	200.00K	Grant	—	Feb 13	View
From 4	—	310.00K	—	—	Jun 05, 2019	310.00K	Grant	—	Jun 03	View
From 4	-0.33	103.36K	$10.00	—	May 13, 2019	206.20K	Buy-Options	—	May 09	View
From 3	—	—	—	—	May 07, 2019	176.61K	—	—	—	View

RYTMrhythm pharmaceuticals, inc.

Updated: Jun 26, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	11.75K	—	—	Jun 26, 2025	11.75K	Grant	—	Jun 24	View
From 4	—	—	—	—	Jun 23, 2025	7.00K	Options	—	Jun 18	View
From 4	-0.91	31.75K	$36.97	-$979.74K	Sep 19, 2024	3.00K	Sale	Scheduled	Sep 17	View
From 4	-0.52	37.24K	$31.90	-$1.38M	Sep 11, 2024	34.75K	Sale	Scheduled	Sep 09	View
From 4	-0.17	14.51K	$34.32	-$455.20K	Aug 28, 2024	71.99K	Sale	Scheduled	Aug 26	View
From 4	—	—	—	—	Jun 25, 2024	3.00K	Options	—	Jun 21	View
From 4	—	18.00K	—	—	Jun 20, 2024	18.00K	Grant	—	Jun 18	View
From 4	—	17.00K	—	—	Jun 23, 2023	17.00K	Grant	—	Jun 21	View
From 4	—	20.00K	—	—	Jun 10, 2022	20.00K	Grant	—	Jun 08	View
From 4	—	15.00K	—	—	Jun 11, 2021	15.00K	Grant	—	Jun 09	View
From 4	—	18.50K	—	—	Jun 18, 2020	18.50K	Grant	—	Jun 17	View
From 4	—	30.00K	—	—	Jun 21, 2019	30.00K	Grant	—	Jun 19	View
From 3	—	—	—	—	Jun 21, 2019	—	—	—	—	View

juniper pharmaceuticals inc

Updated: Aug 15, 2018

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	15.00K	$11.50	-$172.50K	Aug 15, 2018	—	Disposition	—	Aug 14	View
From 4	—	15.00K	—	—	Sep 11, 2017	15.00K	Grant	—	Sep 07	View
From 3	—	—	—	—	Sep 11, 2017	—	—	—	—	View

penwest pharmaceuticals co

President & CEO Officer

Updated: Nov 08, 2010

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Nov 08, 2010	—	—	—	—	View
From 4	-1.00	400.99K	$2.57	-$856.50K	Sep 22, 2010	—	Disposition	—	Sep 20	View
From 4	—	—	$1.56	$39.00K	Apr 28, 2010	135.99K	Options	—	Apr 28	View
From 4	—	140.00K	—	—	Mar 08, 2010	140.00K	Grant	—	Mar 05	View
From 4	0.76	7.50K	$2.14	$16.05K	Nov 12, 2009	32.38K	Purchase	—	Nov 11	View
From 4	—	100.00K	—	—	Mar 09, 2009	100.00K	Grant	—	Mar 05	View
From 4	—	30.00K	—	—	Jun 12, 2008	30.00K	Grant	—	Jun 11	View
From 4	—	100.00K	$2.62	$262.00K	Mar 14, 2008	100.00K	Grant	—	Mar 10	View
From 4	—	65.00K	$13.02	$846.30K	Mar 02, 2007	65.00K	Grant	—	Mar 01	View
From 4	—	50.00K	$22.67	$1.13M	Feb 16, 2006	50.00K	Grant	—	Feb 09	View
From 4	-0.77	19.76K	$8.57	-$356.00K	Dec 06, 2005	5.87K	Sale	—	Dec 02	View
From 4	—	50.00K	$16.14	$807.00K	Nov 28, 2005	50.00K	Grant	—	Nov 23	View
From 4	-0.06	500.00	$8.56	-$9.00K	Oct 05, 2005	7.87K	Sale	—	Oct 03	View
From 4	-0.63	13.18K	$9.68	-$210.59K	Sep 08, 2005	7.87K	Sale	—	Sep 07	View
From 4	-0.44	6.23K	$8.87	-$79.44K	Aug 24, 2005	7.87K	Sale	—	Aug 22	View
From 4	—	—	$5.41	—	Mar 24, 2005	7.87K	Options	—	Mar 24	View
From 4	—	45.00K	$10.35	$465.75K	Feb 18, 2005	45.00K	Grant	—	Feb 16	View
From 4	—	—	$5.41	—	Feb 23, 2004	5.24K	Options	—	Feb 23	View
From 4	—	50.00K	$16.39	$819.25K	Feb 13, 2004	50.00K	Grant	—	Feb 11	View
From 4	—	—	$5.41	—	Dec 04, 2003	2.95K	Options	—	Dec 02	View
From 4	-1.00	12.94K	$9.90	-$270.86K	Sep 15, 2003	—	Sale	—	Sep 11	View

XTLBxtl biopharmaceuticals ltd

Updated: Nov 04, 2008VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Nov 04, 2008	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions